Cost-Effectiveness and Impact of a Targeted Age- and Incidence-based West Nile Virus Vaccine Strategy

• Published in: Clinical infectious diseases Vol. 73; no. 9; pp. 1565 - 1570
• Main Authors: Curren, Emily J, Shankar, Manjunath B, Fischer, Marc, Meltzer, Martin I, Erin Staples, J, Gould, Carolyn V
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 02.11.2021
• Subjects: Cost-Benefit Analysis; Humans; Incidence; United States - epidemiology; West Nile Fever - epidemiology; West Nile Fever - prevention & control; West Nile virus; West Nile Virus Vaccines; United States; cost-effectiveness; West Nile virus; impact; vaccination

Abstract Background West Nile virus (WNV) is the leading cause of arboviral disease in the United States and is associated with significant morbidity and mortality. A previous analysis found that a vaccination program targeting persons aged ≥60 years was more cost-effective than universal vaccinatio...